Effects of oral paricalcitol on hyperparathyroidism and proteinuria in peritoneal dialysis patients.

In conclusion, paricalcitol is effective for treating hyperparathyroidism in patients on peritoneal dialysis and seems also to have an antiproteinuric effect in these patients. PMID: 22073844 [PubMed - indexed for MEDLINE]
Source: Advances in Peritoneal Dialysis. Conference on Peritoneal Dialysis - Category: Urology & Nephrology Tags: Adv Perit Dial Source Type: research